We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Groundbreaking AI Technology Accurately Diagnoses COVID-19 Using Chest X-Rays in Minutes

By HospiMedica International staff writers
Posted on 20 Jan 2022

A pioneering artificial intelligence (AI) technology is capable of accurately diagnosing COVID-19 in just a few minutes. More...

The groundbreaking program developed by researchers at University of the West of Scotland (UWS; Scotland, UK) is able to detect the virus far more quickly than a PCR test; which typically takes around two -hours. It is hoped that the technology can eventually be used to help relieve strain on hard-pressed accident and emergency departments, particularly in countries where PCR tests are not readily available.

The state-of-the-art technique utilizes X-ray technology, comparing scans to a database of around 3,000 images, belonging to patients with COVID-19, healthy individuals and people with viral pneumonia. It then uses an AI process known as deep convolutional neural network, an algorithm typically used to analyze visual imagery, to make a diagnosis. During an extensive testing phase, the technique proved to be more than 98% accurate. The team now plans to expand the study, incorporating a greater database of x-ray images acquired by different models of X-ray machines, to evaluate the suitability of the approach in a clinical setting.

“There has long been a need for a quick and reliable tool that can detect Covid-19, and this has become even more true with the upswing of the Omicron variant,” said Professor Naeem Ramzan, Director of the Affective and Human Computing for SMART Environments Research Centre at UWS, who led the team behind the project. “Several countries are unable to carry out large numbers of COVID tests because of limited diagnosis tools, but this technique utilizes easily accessible technology to quickly detect the virus.”

“COVID-19 symptoms are not visible in X-rays during the early stages of infection, so it is important to note that the technology cannot fully replace PCR tests. However, it can still play an important role in curtailing the viruses spread especially when PCR tests are not readily available. It could prove to be crucial, and potentially life-saving, when diagnosing severe cases of the virus, helping determine what treatment may be required,” added Professor Ramzan.

Related Links:
University of the West of Scotland


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Absorbable Monofilament Mesh
Phasix Mesh
New
MR Trolley
MR9002
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.